Resistance in hematologic malignancies and cancer /
Resistance in Hematologic Malignancies and Cancer brings together the molecular, cellular, and biochemical basis/principles of various mechanisms of resistance to treatment in hematologic malignancies. Even though main mechanisms of resistance are the same in different types of tumours there are spe...
Kaydedildi:
| Diğer Yazarlar: | , |
|---|---|
| Materyal Türü: | Elektronik Ekitap |
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
London, United Kingdom :
Academic Press,
[2025]
|
| Seri Bilgileri: | Cancer sensitizing agents for chemotherapy ;
volume 22 |
| Konular: | |
| Online Erişim: | ScienceDirect |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
İçindekiler:
- Front Cover
- Resistance in Hematologic Malignancies and Cancer
- Copyright
- Cover Image Insert
- Aims and Scope for Series ``Cancer Sensitizing Agents for Chemotherapyþþ
- About the Series Editor
- Acknowledgments
- Aims and Scope of Volume
- Volume Editor Biography
- Preface
- Contents
- Contributors
- Chapter 1: Drug classification for the treatment of hematologic malignancies
- Introduction
- Chemotherapeutic drugs
- Alkylating agents
- Antimetabolites
- Natural alkaloids with antitubulin activity
- Cytotoxic antibiotics
- Fixed-dose combination drugs
- Small-molecule anticancer drugs
- Tyrosine kinase inhibitors
- Multikinase inhibitors
- Phosphatidylinositol 3-kinase inhibitors
- Enzyme inhibitors
- Histone deacetylase inhibitors
- Isocitrate dehydrogenase inhibitors
- Enhancer ofzZeste homolog 2 inhibitor
- DNA and RNA methyltransferases inhibitor
- Smoothed receptor antagonists